• CMS Signed An Exclusive Commercialization and Supply Agreement with Pharmacosmos A/S 4/28/2026
• CMS: NDA for the Seasonal Allergic Rhinitis Indication of Class 1 Innovative Drug MG-K10 A... 4/24/2026
• CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharma... 7/23/2025